Published in Am J Clin Pathol on June 01, 2011
Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol (2012) 2.35
Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics. Cancer Cell (2012) 1.99
Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas. Indian J Med Res (2012) 1.44
Prognostic and Clinicopathological Significance of Transducer-Like Enhancer of Split 1 Expression in Gastric Cancer. J Gastric Cancer (2016) 0.78
BCOR Upregulation in a Poorly Differentiated Synovial Sarcoma with SS18L1-SSX1 Fusion - A Pathologic and Molecular Pitfall. Genes Chromosomes Cancer (2016) 0.77
Nuclear β-Catenin Expression is Frequent in Sinonasal Hemangiopericytoma and Its Mimics. Head Neck Pathol (2016) 0.76
Biphenotypic sinonasal sarcoma: an expanded immunoprofile including consistent nuclear β-catenin positivity and absence of SOX10 expression. Hum Pathol (2016) 0.76
Primary pulmonary poorly differentiated synovial sarcoma: transducer-like enhancer of split 1 immunohistochemistry as a valuable diagnostic aid. J Lab Physicians (2013) 0.75
Primary biphasic synovial sarcoma of gingiva: Report of a rare case. J Oral Maxillofac Pathol (2014) 0.75
Clinical Neuropathology practice guide 6-2013: morphology and an appropriate immunohistochemical screening panel aid in the identification of synovial sarcoma by neuropathologists. Clin Neuropathol (2013) 0.75
Primary synovial cell sarcoma of the kidney: case report and review of the literature. Case Rep Oncol (2015) 0.75
Primary Synovial Sarcoma of the Pharynx: A Series of Five Cases and Literature Review. Head Neck Pathol (2015) 0.75
A challenging case of metastatic intra-abdominal synovial sarcoma with unusual immunophenotype and its differential diagnosis. Case Rep Pathol (2012) 0.75
Diagnostic Approach to Synovial Sarcoma of the Head and Neck Illustrated by Two Cases Arising in the Face and Oral Cavity. Dermatopathology (Basel) (2016) 0.75
TLE1 function and therapeutic potential in cancer. Oncotarget (2016) 0.75
Immunohistochemical Markers of Soft Tissue Tumors: Pathologic Diagnosis, Genetic Contributions, and Therapeutic Options. Anal Chem Insights (2015) 0.75
Cystic synovial sarcoma of the pleura mimicking a cystic thymoma: a case report illustrating the role of decreased INI-1 expression in differential diagnosis. Int J Clin Exp Pathol (2015) 0.75
Antibody-independent capture of circulating tumor cells of non-epithelial origin with the ApoStream® system. PLoS One (2017) 0.75
[Molecular pathology of soft tissue tumors: Contribution to diagnosis and therapy prediction]. Pathologe (2015) 0.75
Primary Renal Sarcomas With BCOR-CCNB3 Gene Fusion: A Report of 2 Cases Showing Histologic Overlap With Clear Cell Sarcoma of Kidney, Suggesting Further Link Between BCOR-related Sarcomas of the Kidney and Soft Tissues. Am J Surg Pathol (2017) 0.75
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med (2010) 6.28
Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol (2007) 6.11
A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry. Clin Cancer Res (2010) 4.51
Cord colitis syndrome in cord-blood stem-cell transplantation. N Engl J Med (2011) 3.83
Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome. N Engl J Med (2013) 3.39
Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol (2007) 3.00
"Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior. Am J Surg Pathol (2011) 2.72
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci U S A (2010) 2.68
Combined use of ALK immunohistochemistry and FISH for optimal detection of ALK-rearranged lung adenocarcinomas. J Thorac Oncol (2013) 2.68
Sentinel lymph node biopsies for cutaneous melanoma. Am J Surg Pathol (2005) 2.68
KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol (2004) 2.51
Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am J Surg Pathol (2006) 2.18
Evidence-based pathology: systematic literature reviews as the basis for guidelines and best practices. Arch Pathol Lab Med (2014) 2.06
Malignant gastrointestinal neuroectodermal tumor: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of 16 cases with a reappraisal of clear cell sarcoma-like tumors of the gastrointestinal tract. Am J Surg Pathol (2012) 2.03
Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know. AJR Am J Roentgenol (2013) 2.03
Generalized bullous eruption after routine vaccination in a child with diffuse cutaneous mastocytosis. J Allergy Clin Immunol Pract (2012) 2.01
O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors. Clin Cancer Res (2009) 2.00
Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am J Surg Pathol (2007) 1.92
Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol (2004) 1.92
Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol (2011) 1.91
Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Am J Surg Pathol (2009) 1.89
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med (2009) 1.85
Localized malignant mesothelioma. Am J Surg Pathol (2005) 1.83
INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol (2011) 1.78
Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience. Gastrointest Endosc (2009) 1.73
Proliferating pilar tumors: a clinicopathologic study of 76 cases with a proposal for definition of benign and malignant variants. Am J Clin Pathol (2004) 1.67
Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila) (2012) 1.65
A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol (2011) 1.64
Extraskeletal osteosarcoma: spectrum of imaging findings. AJR Am J Roentgenol (2012) 1.63
Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin Cancer Res (2007) 1.61
SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Histopathology (2013) 1.60
PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol (2010) 1.57
Calcifying fibrous 'pseudotumor': clinicopathologic study of 15 cases and analysis of its relationship to inflammatory myofibroblastic tumor. Int J Surg Pathol (2002) 1.55
PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors. Am J Surg Pathol (2010) 1.54
Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. Am J Surg Pathol (2010) 1.53
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chim Acta (2012) 1.51
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Transfusion (2012) 1.50
Salivary-type neoplasms of the breast and lung. Semin Diagn Pathol (2003) 1.47
MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol (2011) 1.45
Histopathologic prognosis of thymomas: another example of medical surrogacy. Am J Clin Pathol (2010) 1.45
Melanocytic lesions with features of Spitz nevus. Hum Pathol (2006) 1.39
Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer. Clin Cancer Res (2009) 1.39
Immunostaining for MART-1 in the interpretation of problematic intra-epidermal pigmented lesions. J Cutan Pathol (2007) 1.38
DOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks. Am J Clin Pathol (2011) 1.36
Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas. Appl Immunohistochem Mol Morphol (2010) 1.34
Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. PLoS One (2013) 1.32
The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans. Cancer Cell (2006) 1.30
Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. Genes Chromosomes Cancer (2013) 1.29
Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model. J Immunol (2008) 1.27
Imaging features of primary and metastatic malignant perivascular epithelioid cell tumors. AJR Am J Roentgenol (2014) 1.26
Mucosal Schwann cell "hamartoma": clinicopathologic study of 26 neural colorectal polyps distinct from neurofibromas and mucosal neuromas. Am J Surg Pathol (2009) 1.25
Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors. Am J Clin Pathol (2007) 1.22
Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma. Histopathology (2013) 1.21
Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Am J Surg Pathol (2009) 1.19
Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer. Ann Surg Oncol (2011) 1.16
IgG4 plasma cells in inflammatory myofibroblastic tumor: inflammatory marker or pathogenic link? Mod Pathol (2011) 1.16
gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J Immunol (2005) 1.15
Chronically inflamed livers up-regulate expression of inhibitory B7 family members. Hepatology (2009) 1.15
Primary cutaneous PEComa: distinctive clear cell lesions of skin. Am J Surg Pathol (2008) 1.13
Leiomyosarcoma of the inferior vena cava: survival after aggressive management. Ann Surg Oncol (2007) 1.10
Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. Am J Surg Pathol (2014) 1.09
MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Am J Surg Pathol (2012) 1.08
Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs). Cancer Res (2004) 1.08
EMR of ampullary gangliocytic paragangliomas. Gastrointest Endosc (2005) 1.07
Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases. Histopathology (2012) 1.07
Epithelioid sarcoma and unclassified sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental model. Oncologist (2011) 1.07
Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations. J Allergy Clin Immunol (2011) 1.07
Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications. Am J Surg Pathol (2012) 1.07
Epicutaneous challenge of orally immunized mice redirects antigen-specific gut-homing T cells to the skin. J Clin Invest (2011) 1.06
Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors. Mod Pathol (2012) 1.05
Protocol for the examination of specimens from patients with merkel cell carcinoma of the skin. Arch Pathol Lab Med (2010) 1.04
Podoplanin (D2-40) is a highly effective marker of follicular dendritic cells. Appl Immunohistochem Mol Morphol (2009) 1.03
A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients. Am J Surg Pathol (2014) 1.03
Multiple primary sporadic gastrointestinal stromal tumors in the adult: an underestimated entity. Clin Cancer Res (2008) 1.03
Cardiac angiosarcoma management and outcomes: 20-year single-institution experience. Ann Surg Oncol (2012) 1.03
Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience. Ann Surg Oncol (2013) 1.02
Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. AJR Am J Roentgenol (2012) 1.02
Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas. Am J Surg Pathol (2007) 1.02
Primary follicular dendritic cell sarcoma of liver treated with cyclophosphamide, doxorubicin, vincristine, and prednisone regimen and surgery. J Clin Oncol (2011) 1.02
Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations. Cancer (2013) 1.01
p63 Expression in olfactory neuroblastoma and other small cell tumors of the sinonasal tract. Am J Clin Pathol (2008) 1.01
A novel blueprint for 'top down' differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia. J Pathol (2013) 1.00
SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract. Hum Pathol (2009) 1.00
PEComa of the gastrointestinal tract: clinicopathologic study of 35 cases with evaluation of prognostic parameters. Am J Surg Pathol (2013) 1.00
Cutaneous syncytial myoepithelioma: clinicopathologic characterization in a series of 38 cases. Am J Surg Pathol (2013) 0.98
Primary sclerosing epithelioid fibrosarcoma of bone: analysis of a series. Am J Surg Pathol (2014) 0.98
Interobserver variability in the diagnosis of crypt dysplasia in Barrett esophagus. Am J Surg Pathol (2011) 0.98
Solitary fibrous tumors of the skin: a clinicopathologic study of 10 cases and review of the literature. J Cutan Pathol (2007) 0.97
Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies. Arch Surg (2012) 0.97
Evidence-based medicine, medical decision analysis, and pathology. Hum Pathol (2004) 0.97
Contemporary pathology of gastrointestinal stromal tumors. Hematol Oncol Clin North Am (2009) 0.97
Protocol for the examination of specimens from patients with melanoma of the skin. Arch Pathol Lab Med (2009) 0.97
Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee. Appl Immunohistochem Mol Morphol (2015) 0.97
Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis. Am J Surg Pathol (2007) 0.96
Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria. Am J Surg Pathol (2010) 0.96
Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis. Mod Pathol (2013) 0.95
Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes. Immunol Res (2009) 0.95
Comparative analysis of FcεRI expression patterns in patients with eosinophilic and reflux esophagitis. J Pediatr Gastroenterol Nutr (2010) 0.95
Inflammatory pseudotumor (myofibroblastic tumor) of the heart. Ann Diagn Pathol (2002) 0.94
Retracted SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function. J Virol (2005) 0.94